Abstract:Aims/hypothesis: Progression to type 1 diabetes (T1D) is associated with genetic factors, the presence of autoantibodies, and a decline in beta cell insulin secretion in response to glucose. Very little is known regarding the molecular changes that occur in human insulin-secreting beta-cells prior to the onset of T1D. Herein, we applied an unbiased proteomics approach to identify changes in proteins and potential mechanisms of islet dysfunction in islet autoantibody-positive organ donors with pre-symptomatic stage 1 T1D (HbA1c less than 6). We aimed to identify pathways in islets that are indicative of beta-cell dysfunction. Methods: Multiple islet sections were collected through laser microdissection of frozen pancreatic tissues of organ donors positive for islet autoantibodies (AAb+, n=5), compared to age/sex-matched nondiabetic controls (ND, n=5) obtained from the Network for Pancreatic Organ donors with Diabetes (nPOD). Islet sections were subjected to mass spectrometry-based proteomics and analyzed with label-free quantification followed by pathway and functional annotations. Results: Analyses resulted in ~4,500 proteins identified with low false discovery rate (FDR) <1%, with 2,165 proteins reliably quantified in every islet sample. We observed large inter-donor variations that presented a challenge for statistical analysis of proteome changes between donor groups. We therefore focused on the three multiple AAb+ cases (mAAb+) with high genetic risk and their three matched controls for a final statistical analysis. Approximately 10% of the proteins (n=202) were significantly different between mAAb+ cases versus ND. The significant alterations clustered around major functions for upregulation in the immune response and glycolysis, and downregulation in endoplasmic reticulum (ER) stress response as well as protein translation and synthesis. The observed proteome changes were further supported by several independent published datasets, including proteomics dataset from in vitro proinflammatory cytokine-treated human islets and single cell RNA-seq data sets from AAb+ cases. Conclusion/interpretation: In-situ human islet proteome alterations at the stage 1 of AAb+ T1D centered around several major functional categories, including an expected increase in immune response genes (elevated antigen presentation / HLA), with decreases in protein synthesis and ER stress response, as well as compensatory metabolic response. The dataset serves as a proteomics resource for future studies on β cell changes during T1D progression and pathogenesis.

Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis

The Study on the Risk of Other Endocrine Glands Autoimmune Diseases in Patients with Type 1 Diabetes Mellitus

A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion

Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes

Metabolomics and Lipidomics Studies in Pediatric Type 1 Diabetes: Biomarker Discovery for the Early Diagnosis and Prognosis

Evaluating the Diagnostic Accuracy of Anti- Zinc Transporter 8 Antibodies in Type 1 Diabetes: A Systematic Review and Meta-Analysis

Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

Autoantibody "Subspecificity" In Type 1 Diabetes - Risk For Organ-Specific Autoimmunity Clusters In Distinct Groups

Clinical study of autoantibodies in type 1 diabetes mellitus children with ketoacidosis or microalbuminuria

Increased Inflammation as well as Decreased Endoplasmic Reticulum Stress and Translation Differentiate Pancreatic Islets of Pre-symptomatic Stage 1 Type 1 Diabetes and Non-diabetic Cases

Autoantibodies against beta cells to predict early insulin requirements in pediatric patients with clinically diagnosed type 2 diabetes

Advances in the Cellular Immunological Pathogenesis of Type 1 Diabetes.

A surge in serum mucosal cytokines associated with seroconversion in children at risk for type 1 diabetes

Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes

Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes

The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients

Immunogenetics of type 1 diabetes: A comprehensive review

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles

Research progress on immunology of type 1 diabetes mellitus

Serum IL-17A concentration and a IL17RA single nucleotide polymorphism contribute to the risk of autoimmune type 1 diabetes

The Pathogenesis of Type 1 Diabetes